Accuray Incorporated announced that Mr. Joshua Levine will retire from the Accuray Board of Directors at the end of the company's fiscal year on June 30, 2022 and will remain available to the company in a consulting role through June 30, 2023 to ensure a smooth transition over the next year. Ms. Suzanne Winter has been appointed as a director of the company and will join the Board effective April 27, 2022. Ms. Winter joined Accuray as Senior Vice President, Chief Commercial Officer in October 2019 and has served as the company's President since July 2021.

In this role she directs the Company's day-to-day operations, leads its global growth initiatives, and manages its innovation, regulatory and clinical efforts. During her tenure, Ms. Winter has implemented bold, forward-looking strategies including refocused investment in innovation and high impact product introductions delivering historic commercial results. Accuray announced that Ali Pervaiz has been appointed Senior Vice President of company, effective May 9, 2022.

Pervaiz has been with Accuray for two years and currently serves as the company's Vice President, Global Commercial Operations. Mr. Pervaiz previously held the roles of Chief Financial Officer for two GE Healthcare business units including the $1.3 billion US Imaging Equipment and $650 million US Life Support Solutions business.